SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000912057-01-527354
Filing Date
2001-08-09
Accepted
2001-08-09 00:00:00
Documents
9
Period of Report
2001-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2055840z10-q.htm 10-Q 255493
3 EXHIBIT 3.2 a2055840zex-3_2.txt EX-3.2 4296
4 EXHIBIT 10.1 a2055840zex-10_1.txt EX-10.1 47482
5 EXHIBIT 10.2 a2055840zex-10_2.txt EX-10.2 47435
6 EXHIBIT 10.3 a2055840zex-10_3.txt EX-10.3 48224
7 EXHIBIT 10.4 a2055840zex-10_4.txt EX-10.4 47637
8 EXHIBIT 10.5 a2055840zex-10_5.txt EX-10.5 47491
9 EXHIBIT 10.6 a2055840zex-10_6.txt EX-10.6 44361
10 EXHIBIT 10.7 a2055840zex-10_7.txt EX-10.7 30405
  Complete submission text file 0000912057-01-527354.txt   575218
Mailing Address 1600 FARADAY AVE CARLSBAD CA 92008
Business Address 1600 FARADAY AVE CARLSBAD CA 92008 7606037200
INVITROGEN CORP (Filer) CIK: 0001073431 (see all company filings)

IRS No.: 330373077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25317 | Film No.: 1702675
SIC: 2836 Biological Products, (No Diagnostic Substances)